Join us on Thursday, September 22, at 1 pm ET. Dr. Jeffrey Cummings will discuss drug development and the changing Alzheimer's Disease therapeutic landscape. Dr. Cummings will review in great length the following key items: Candidate treatments in the drug development pipeline are directed at a wide variety of targets Biomarkers play multiple key roles [...]